Stock Message Board http://investorshangout.com/search?q=BIIB&...mp;yt1=Go!
Last Updated: Sunday, April 27, 2014 8:29:11 PM
Biogen Idec, Inc. BIIB Current Price and Quotes
Last Price 285.81
Previous Close 294.84 Open 293.04
Daily Range 285.58 - 296.74 52wk Range 194.66 - 358.89
Volume 1,727,651 Dividend N/A
Average Vol (3m) 1,771,699 Yield N/A
Biogen Idec, Inc. BIIB
Biogen Idec, Inc. BIIB
Biogen Idec, Inc. BIIB
Biogen Idec, Inc. BIIB
Biogen Idec, Inc. BIIB Financials
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 6,932,199 5,516,461 5,048,634 4,716,423
Cost of Revenue 857,726 545,494 466,780 400,262
Gross Profit 6,074,473 4,970,967 4,581,854 4,316,161
Operating Expenses
Research and Development 1,444,053 1,334,919 1,219,602 1,248,604
Sales, General and Admin. 1,796,861 1,622,562 1,409,969 1,289,611
Non-Recurring Items - 2,225 19,026 320,129
Other 342,948 202,204 208,566 208,928
Operating Income 2,515,509 1,855,849 1,724,691 1,248,889
Income From Continuing Operations
Add'l Income/Expense Items (10,032) 46,048 (13,477) (18,983)
Earnings Before Interest and Tax 2,505,477 1,901,897 1,711,214 1,229,906
Interest Expense - - - -
Earnings Before Tax 2,505,477 1,901,897 1,711,214 1,229,906
Income Tax 601,014 470,554 444,528 331,333
Minority Interest - - 32,258 (106,700)
Equity Earnings Unconsolidated Subsidiary (17,224) (4,518) - -
Net Income Cont. Operations 1,887,239 1,426,825 1,234,428 1,005,273
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 1,862,341 1,380,033 1,234,428 1,005,273
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 1,862,341 1,380,033 1,234,428 1,005,273
Biogen Idec, Inc. BIIB Recent News
Apr 24, 2014 Quintiles and Biogen Idec Announce Comprehensive Clinical Development Partnership
Apr 23, 2014 Alliance Fiber Optic, Talisman Energy, Gilead Sciences, Biogen Idec and Alexion Pharmaceuticals highlighted as Zacks Bull and Bear of the Day
Apr 23, 2014 Biogen Idec First Quarter 2014 Revenues Reach $2.1 Billion Driven by Continued Strength of MS Franchise
Apr 21, 2014 Biogen Idec Signs License Agreement With Amunix for XTENylated Factor VIII
Apr 15, 2014 Surveyed European Neurologists Expect to Prescribe Biogen Idec's Tecfidera to 16 Percent of their Diagnosed Relapsing-Remitting Multiple Sclerosis Patients in the Next 12 Months
Apr 14, 2014 Biogen Idec to Present New Clinical Data from Its Robust Neurology Portfolio at AAN Annual Meeting
Apr 14, 2014 R&D Expert Hosts Webinar on Lab Scale Manufacturing Using Continuous Crystallization
Apr 11, 2014 Pfizer's Ian Read Becomes PhRMA Board Chairman; Ken Frazier, George Scangos Assume New Posts
Apr 10, 2014 Biogen Idec Names Adam M. Koppel as SVP and Chief Strategy Officer
Apr 10, 2014 Biogen Idec and Sobi announce positive top-line efficacy and safety results from phase-3 paediatric study of investigational therapy Eloctate(TM) (rFVIIIFc) for haemophilia A
1
2
3
4
5
next >
BIIB Biogen Idec, Inc. Research DD Guide
Stock Message Board http://investorshangout.com/search?q=BIIB&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/BIIB/quote
Stock Chart http://www.otcmarkets.com/stock/BIIB/chart
Company Info http://www.otcmarkets.com/stock/BIIB/company-info
Recent News http://www.otcmarkets.com/stock/BIIB/news
Financials http://www.otcmarkets.com/stock/BIIB/financials
Filings and Disclosure http://www.otcmarkets.com/stock/BIIB/filings
Short Sales http://www.otcmarkets.com/stock/BIIB/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/BIIB/insider-transactions
Research Reports http://www.otcmarkets.com/stock/BIIB/research
Summary http://finance.yahoo.com/q?s=BIIB
Historical Prices http://finance.yahoo.com/q/hp?s=BIIB+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=BIIB
Basic Chart http://finance.yahoo.com/q/bc?s=BIIB+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=BIIB+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=BIIB+Headlines
Press Releases http://finance.yahoo.com/q/p?s=BIIB+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=BIIB+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=BIIB+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=BIIB+Industry
Major Holders http://finance.yahoo.com/q/mh?s=BIIB+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=BIIB+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=BIIB+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=BIIB
Balance Sheet http://finance.yahoo.com/q/bs?s=BIIB
Cash Flow http://finance.yahoo.com/q/cf?s=BIIB+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/BIIB
Market Watch http://www.marketwatch.com/investing/stock/BIIB
Bloomberg http://www.bloomberg.com/quote/BIIB:US
Morningstar http://quotes.morningstar.com/stock/s?t=BIIB
Bussinessweek http://investing.businessweek.com/research/st...icker=BIIB
Barchart http://www.barchart.com/quotes/stocks/BIIB
OTC Short Report http://otcshortreport.com/index.php?index=BIIB
Investopedia http://www.investopedia.com/markets/stocks/BIIB/?wa=0